Cybersecurity
Why cyber resilience in pharma must extend into medicine value chains
Cyber resilience in pharma and life sciences is no longer restricted to protecting systems, but also ensuring that medicines remain available to patients
Ashish Gupta
Ashish Gupta is a Partner in PwC Switzerland’s Cybersecurity practice, focusing on cyber resilience and transformation for pharmaceutical, life sciences and manufacturing companies globally.
He advises senior executives and boards on cybersecurity strategy and transformation, helping organizations connect technology and cyber risks with business and operational priorities. His recent work focuses on advancing a medicine value chain-based approach to resilience, addressing critical dependencies across pharmaceutical manufacturing, supply chains and third-party ecosystems that can affect medicine availability.
Ashish’s broader areas of expertise include digital identity, operational technology and manufacturing security, cyber risk & regulatory, AI and digital trust. He regularly contributes to industry dialogue on cyber resilience and writes for the World Economic Forum.
Most Popular